Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
Santiago Duro‐Sánchez(Universitat Autònoma de Barcelona), Joaquı́n Arribas(Institució Catalana de Recerca i Estudis Avançats)
Cited by 41
Related Papers
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
|Nature Communications|2021|56
Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence
|Breast Cancer Research|2015|13